TY - JOUR AU - Siegel, R. L. PY - 2018 DA - 2018// TI - Cancer statistics JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21442 DO - 10.3322/caac.21442 ID - Siegel2018 ER - TY - JOUR AU - Goldstraw, P. AU - Chansky, K. AU - Crowley, J. PY - 2016 DA - 2016// TI - The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.09.009 DO - 10.1016/j.jtho.2015.09.009 ID - Goldstraw2016 ER - TY - JOUR AU - Pignon, J. P. AU - Tribodet, H. AU - Scagliotti, G. V. PY - 2008 DA - 2008// TI - Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.9030 DO - 10.1200/JCO.2007.13.9030 ID - Pignon2008 ER - TY - JOUR AU - Douillard, J. Y. AU - Rosell, R. AU - Lena, M. PY - 2006 DA - 2006// TI - Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant Navelbine international Trialist association [ANITA]): a randomized controlled trial JO - Lancet Oncol VL - 7 UR - https://doi.org/10.1016/S1470-2045(06)70804-X DO - 10.1016/S1470-2045(06)70804-X ID - Douillard2006 ER - TY - JOUR AU - Pisters, K. M. AU - Evans, W. K. AU - Azzoli, C. G. PY - 2007 DA - 2007// TI - Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small-cell lung cancer guideline JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.14.1226 DO - 10.1200/JCO.2007.14.1226 ID - Pisters2007 ER - TY - STD TI - National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. lung Cancer (Version 3.2011)[DB/OL]. http://www.nccn.org. UR - http://www.nccn.org ID - ref6 ER - TY - JOUR AU - Winton, T. AU - Livingston, R. AU - Johnson, D. PY - 2005 DA - 2005// TI - Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043623 DO - 10.1056/NEJMoa043623 ID - Winton2005 ER - TY - JOUR AU - Wang, J. AU - Chen, Y. L. AU - Ping, C. PY - 2016 DA - 2016// TI - Clinical observations on treating 40 cases of locally advanced non-small-cell lung cancer with the Zilongjin tablet JO - Chin J Trad Chin Med VL - 8 ID - Wang2016 ER - TY - JOUR AU - Liang, J. AU - Zhang, L. PY - 2013 DA - 2013// TI - Survival effect of Rongyan capsule, a maintenance treatment for advanced non-small-cell lung cancer JO - Sichuan Zhong Yi VL - 1 ID - Liang2013 ER - TY - JOUR AU - Zhao, X. AU - Dai, X. AU - Wang, S. PY - 2018 DA - 2018// TI - Traditional Chinese medicine integrated with chemotherapy for stage II-IIIA patients with non-small-cell lung cancer after radical surgery: a retrospective clinical analysis with small sample size JO - Evid Based Complement Alternat Med VL - 10 ID - Zhao2018 ER - TY - JOUR AU - Jiao, L. AU - Dong, C. AU - Liu, J. PY - 2017 DA - 2017// TI - Effects of Chinese medicine as adjunct medication for adjuvant chemotherapy treatments of non-small cell lung cancer patients JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep46524 DO - 10.1038/srep46524 ID - Jiao2017 ER - TY - JOUR AU - Wang, Q. AU - Jiao, L. AU - Wang, S. PY - 2018 DA - 2018// TI - Maintenance chemotherapy with Chinese herb medicine formulas vs. with placebo in patients with advanced non-small cell lung cancer after first-line chemotherapy: a multicenter, randomized, double-blind trial JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.01233 DO - 10.3389/fphar.2018.01233 ID - Wang2018 ER - TY - JOUR AU - Nakaya, S. PY - 2003 DA - 2003// TI - Question about clinical trial of traditional Chinese medicine JO - Prog Japanese Med VL - 24 ID - Nakaya2003 ER - TY - JOUR AU - Wang, R. AU - Luo, D. AU - He, Z. PY - 2014 DA - 2014// TI - Objective evaluation of Huoxiang Zhengqi particles placebo JO - Chin J Exp Tradit Med Formulae VL - 20 ID - Wang2014 ER - TY - JOUR AU - Scagliotti, G. V. AU - Pastorino, U. AU - Johan, F. PY - 2012 DA - 2012// TI - Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non–small-cell lung cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.33.7089 DO - 10.1200/JCO.2010.33.7089 ID - Scagliotti2012 ER - TY - JOUR AU - Strauss, G. M. AU - Herndon, J. E. AU - Maddaus, M. A. PY - 2008 DA - 2008// TI - Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.4855 DO - 10.1200/JCO.2008.16.4855 ID - Strauss2008 ER - TY - JOUR AU - Tsao, M. S. AU - Marguet, S. AU - Teuff, G. PY - 2015 DA - 2015// TI - Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection JO - J Clin Oncol VL - 58 ID - Tsao2015 ER - TY - JOUR AU - Ma, M. AU - She, Y. AU - Ren, Y. PY - 2018 DA - 2018// TI - Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma JO - J Thorac Dis VL - 10 UR - https://doi.org/10.21037/jtd.2018.08.64 DO - 10.21037/jtd.2018.08.64 ID - Ma2018 ER - TY - JOUR AU - Qian, F. AU - Yang, W. AU - Wang, R. PY - 2017 DA - 2017// TI - Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma JO - J Thorac Cardiovasc Surg VL - S0022-5223 ID - Qian2017 ER - TY - JOUR AU - Fu, Y. L. AU - Tu, H. B. AU - Dong, Z. Y. PY - 2015 DA - 2015// TI - Correlation of TCM syndrome types, TNM staging and tumor antigen in lung cancer JO - World Sci Technol Modern Trad Chin Med VL - 17 ID - Fu2015 ER -